Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats

Infection and Immunity

Volumn 65, Issue 8, 1997, Pages 3399-3405

  De Bernardis, Flavia ^a   Boccanera, Maria ^a   Adriani, Daniela ^a   Spreghini, Elisabetta ^b   Santoni, Giorgio ^b   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; ASPARTIC PROTEINASE; MANNAN; MONOCLONAL ANTIBODY; PEPSTATIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; FEMALE; HUMORAL IMMUNITY; INFECTION RESISTANCE; NONHUMAN; PASSIVE IMMUNIZATION; PRIMARY INFECTION; PRIORITY JOURNAL; RAT; SUPERINFECTION; VACCINATION; VAGINA CANDIDIASIS;

EID: 0030749898     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.8.3399-3405.1997     Document Type: Article

References (44)

1. Borg, M., and R. Rüchel. 1988. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56:626-631.
2. Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationship of Candida albicans. Microbiol. Rev. 55:1-20.
3. Cantorna, M. T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
4. Cassone, A., F. De Bernardis, F. Mondello, T. Ceddia, and L. Agatensi. 1987. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J. Infect. Dis. 156:777-783.
5. Cassone, A., A. Torosantucci, M. Buccanera, G. Pellegrini, C. Palma, and F. Malavasi. 1988. Production and characterization of a monoclonal antibody to a cell surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J. Med. Microbiol. 27:233-238.
6. Cassone, A. 1989. Cell wall of Candida albicans: its functions and its impact on the host. Curr. Top. Med. Mycol. 3:249-314.
7. Cassone, A., M. Boccanera, D. Adriani, G. Santoni, and F. De Bernardis. 1995. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun. 63:2619-2624.
8. Cassone, A., S. Conti, F. De Bernardis, and L. Polonelli. 1997. Antibodies, kilter toxins and antifungal immunoprotection: a lesson from nature? Immunol. Today 18:164-169.
9. Chambers, W. H., N. L. Vujanovic, A. B. De Leo, M. W. Olskowy, R. B. Herbeman, and J. C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine activated killer cells. J. Exp. Med. 169:1373-1389.
10. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
11. De Bernardis, F., L. Agatensi, I. K. Ross, G. W. Emerson, R. Lorenzini, P. A. Sullivan, and A. Cassone. 1990. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161:1276-1283.
12. De Bernardis, F., D. Adriani, R. Lorenzini, E. Pontieri, G. Carruba, and A. Cassone. 1993. Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection. Infect. Immun. 61:1500-1508.
13. De Bernardis, F., A. Molinari, M. Boccanera, A. R. Stringaro, R. Robert, J. M. Senet, G. Arancia, and A. Cassone. 1994. Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis. Infect. Immun. 62:509-519.
14. De Bernardis, F., A. Cassone, J. Sturtevant, and R. Calderone. 1995. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect. Immun. 63:1887-1892.
15. Domer, J. E. 1989. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit. Rev. Immunol. 17:33-51.
16. Fallon, K., K. Bausch, J. Noonan, E. Huguenel, and P. Tamburini. 1997. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun. 65:551-556.
17. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1993. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect. Immun. 61:4202-4207.
18. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1993. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 61:1990-1995.
19. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1994. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect. Immun. 62:1032-1038.
20. Fidel, P. L., Jr., M. E. Lynch, D. H. Conaway, L. Tait, and J. D. Sobel. 1995. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63:547-553.
21. Fidel, P. L., Jr., and J. D. Sobel. 1996. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev. 9:335-348.
22. Ghannoum, M. A., and K. Abu Elteen. 1986. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol. 24:407-413.
23. Gomez, M. J., A. Torosantucci, S. Arancia, B. Maras, L. Parisi, and A. Cassone. 1996. Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans. Infect. Immun. 64:2577-2584.
24. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
25. Hube, B., M. Monod, D. A. Schofield, A. J. P. Brown, and N. A. R. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases of Candida albicans. Mol. Microbiol. 14:87-99.
26. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7:55-69.
27. Kanbe, T., and J. E. Cutler. 1994. Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect. Immun. 62:1662-1668.
28. Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.
29. MacDonald, F., and F. C. Odds. 1983. Virulence for mice of a proteinase secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129:431-438.
30. Magliani, W., S. Conti, F. De Bernardis, M. Gerloni, D. Bertolotti, P. Mozzoni, A. Cassone, and L. Polonelli. 1997. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15:155-158.
31. Mangeney, M., A. Fisher, F. le Deist, J. P. Latgé, and A. Durandy. 1989. Direct activation of human B lymphocytes by Candida albicans-derived mannan antigen. Cell. Immunol. 122:329-337.
32. Mariani, M., M. Cianfriglia, and A. Cassone. 1989. Is mouse IgM purification on protein A possible? Immunol. Today 10:115-116.
33. Mathews, R., and J. Burnie. 1992. The role of hsp90 in fungal infection. Immunol. Today 13:345-348.
34. Mathur, S., G. Virella, J. Koistinen, E. O. Horger, A. Mahvi, and H. H. Fudenberg. 1992. Humoral immunity in vaginal candidiasis. Infect. Immun. 15:287-294.
35. Mencacci, A., A. Torosantucci, R. Spaccapelo, L. Romani, F. Bistoni, and A. Cassone. 1994. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect. Immun. 62:5353-5360.
36. Polonelli, L., F. De Bernardis, S. Conti, M. Boccanera, M. Gerloni, G. Morace, W. Magliani, C. Chezzi, and A. Cassone. 1994. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol. 152:3175-3182.
37. Polonelli, L., F. de Bernardis, S. Conti, M. Boccanera, W. Magliani, M. Gerloni, C. Cantelli, and A. Cassone. 1996. Human natural yeast killer toxin-like candidacidal antibodies. J. Immunol. 156:1880-1885.
38. Ross, I. K., F. de Bernardis, G. W. Emerson, A. Cassone, and P. Sullivan. 1990. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J. Gen. Microbiol. 136:687-694.
39. Ruchel, R., B. Ritter, and M. Schaffrinski. 1990. Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentralbl. Bakteriol. 273:391-403.
40. Sobel, J. D., G. Muller, and H. R. Buckley. 1984. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect. Immun. 44:576-580.
41. Sobel, J. D. 1985. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 152:924-935.
42. Stein, K. E. 1992. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165(Suppl. 1):49-52.
43. Torosantucci, A., C. Palma, M. Boccanera, C. M. Ausiello, G. C. Spagnoli, and A. Cassone. 1990. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J. Gen. Microbiol. 136:2155-2163.
44. Torosantucci, A., C. Bromuro, M. J. Gomez, C. M. Ausiello, F. Urbani, and A. Cassone. 1993. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. J. Infect. Dis. 168:427-435.